ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases

por Cappuzzo, F, Calandri, C, Bartolini, S, Crinò, L
Publicado 2003

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

por Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Publicado 2003

Cancer of the endometrium

por Brémond, A, Bataillard, A, Thomas, L, Achard, J L, Fervers, B, Fondrinier, E, Lansac, J, Bailly, C, Hoffstetter, S, Basuyau, J P, d'Anjou, J, Descamps, P, Farsi, F, Guastalla, J P, Laffargue, F, Rodier, J F, Vincent, P, Pigneux, J
Publicado 2001

Carcinoma of the cervix

por Resbeut, M, Fondrinier, E, Fervers, B, Haie-Meder, C, Bataillard, A, Lhommé, C, Asselain, B, Basuyau, J P, Brémond, A, Castaigne, D, Dubois, J B, Houvenaeghel, G, Lartigau, E, Leblanc, E, Sastre-Garaud, X, Ternier, F, Guastalla, J P, Chauvergne, J
Publicado 2001

The role of aspirin in carcinogenesis

por Caine, G J, Kehoe, S T, Lip, G Y H
Publicado 2002

Alcohol, tobacco and breast cancer: should alcohol be condemned and tobacco acquitted?

por Silva, I dos Santos
Publicado 2002

Targeted radiotherapy of brain tumours

por Zalutsky, M R
Publicado 2004

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

por Pontisso, P, Calabrese, F, Benvegnù, L, Lise, M, Belluco, C, Ruvoletto, M G, De Falco, S, Marino, M, Valente, M, Nitti, D, Gatta, A, Fassina, G
Publicado 2004

Targeting cytotoxic T lymphocytes for cancer immunotherapy

por Maher, J, Davies, E T
Publicado 2004

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualization of postoperative therapy

por Maeda, J, Hirano, T, Ogiwara, A, Akimoto, S, Kawakami, T, Fukui, Y, Oka, T, Gong, Y, Guo, R, Inada, H, Nawa, K, Kojika, M, Suga, Y, Ohira, T, Mukai, K, Kato, H
Publicado 2008

Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

por Linton, K M, Hey, Y, Saunders, E, Jeziorska, M, Denton, J, Wilson, C L, Swindell, R, Dibben, S, Miller, C J, Pepper, S D, Radford, J A, Freemont, A J
Publicado 2008

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer

por Suzuki, H, Toyota, M, Carraway, H, Gabrielson, E, Ohmura, T, Fujikane, T, Nishikawa, N, Sogabe, Y, Nojima, M, Sonoda, T, Mori, M, Hirata, K, Imai, K, Shinomura, Y, Baylin, S B, Tokino, T
Publicado 2008

Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

por Massard, C, Voigt, J-J, Laplanche, A, Culine, S, Lortholary, A, Bugat, R, Theodore, C, Priou, F, Kaminsky, M-C, Lesimple, T, Pivot, X, Coudert, B, Douillard, J-Y, Merrouche, Y, Fizazi, K
Publicado 2008

Birth characteristics and risk of colorectal cancer: a study among Swedish twins

por Cnattingius, S, Lundberg, F, Iliadou, A
Publicado 2009

Integrating BRAF/MEK inhibitors into combination therapy for melanoma

por Smalley, K S M, Flaherty, K T
Publicado 2009

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs

por Ashley, D M, Riffkin, C D, Lovric, M M, Mikeska, T, Dobrovic, A, Maxwell, J A, Friedman, H S, Drummond, K J, Kaye, A H, Gan, H K, Johns, T G, Hawkins, C J
Publicado 2009

Direct effects of doxorubicin on skeletal muscle contribute to fatigue

por van Norren, K, van Helvoort, A, Argiles, J M, van Tuijl, S, Arts, K, Gorselink, M, Laviano, A, Kegler, D, Haagsman, H P, van der Beek, E M
Publicado 2009

Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice

por van Norren, K, Kegler, D, Argilés, J M, Luiking, Y, Gorselink, M, Laviano, A, Arts, K, Faber, J, Jansen, H, van der Beek, E M, van Helvoort, A
Publicado 2009

Childhood exposure to external ionising radiation and solid cancer risk

por Sadetzki, S, Mandelzweig, L
Publicado 2009

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

por Paré, L, Marcuello, E, Altés, A, del Río, E, Sedano, L, Salazar, J, Cortés, A, Barnadas, A, Baiget, M
Publicado 2009